As a company who neither prescribes nor fulfills medications, you might wonder why we care about compounded GLP-1s
#iHeardSTL #FDA #GLP1 Have a question, comment, or feedback
At 24 weeks, least-squares mean changes from baseline in HbA1c with retatrutide were 0.43% for the 0.5 mg group, 1.39% for the 4 mg escalation group, 1.30% for the 4 mg group, 1.99% for the 8 mg slow escalation group, 1.88% for the 8 mg fast escalation group, and 2.02% for the 12 mg escalation group, versus 0.01% for the placebo group and 1.41% for the 1.5 mg dulaglutide group
can help ensure value for money and better sourcing decisions
We paused
The Nutrition Protocol That Maximizes Results Retatrutide changes the way your body processes food and registers hunger